Concerns about liver toxicity are fueling changes for pemoline and Cymbalta

December 2005

Concerns about liver toxicity are fueling changes for pemoline and Cymbalta.

Pemoline will go off the market...due to liver failure.

Your patients can continue to receive pemoline until it runs out. But switch to a different ADHD med as soon as possible.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Electronic prescribing will usher in a new era of "second generation" med errors
Women's Health whether they should stop using the Ortho Evra contraceptive patch
Women's Health new human papillomavirus (HPV) vaccines
Neurology & Pain avoid alcohol while taking Avinza or Kadian (long-acting morphine)
Infectious Diseases FDA says antibacterial soaps and washes aren't any better than plain soap and water for home use
Infectious Diseases Can patients with a penicillin allergy take cephalosporins or other beta-lactam antibiotics?
Dyslipidemia whether patients can use other niacin products in place of Niaspan
Diabetes DISPOSABLE blood glucose meter called Sidekick
Cardiology amiodarone drug interactions
Concerns about liver toxicity are fueling changes for pemoline and Cymbalta
Combining a triptan and an NSAID is more effective than either drug alone for treating migraines
Supplements Cold-fX prevents the common cold
Supplements Brazilian Diet Pills
people to learn more about their family health history
Practice glucosamine, chondroitin, and selenium for osteoarthritis